Birzeit Pharmaceuticals Company announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $5,480,204, compared with a net profit after taxes of $4,785,914 in the audited data for 2012, a net increase of 14.5%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +0.25% | -0.74% | -8.47% |
02-25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-09 | What does the Gotham City report say about Grifols? | RE |
1st Jan change | Capi. | |
---|---|---|
-8.47% | 155M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- BPC Stock
- News Birzeit Pharmaceuticals Company
- Birzeit Pharmaceuticals Company Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013